MedTrace Logo

Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts

NCT05115669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-02-21

No results posted yet for this study

Summary

This is a Post-Market clinical Follow-up investigation to evaluate the safety and performed of the medical device Wortie Freeze Plus in the treatment of common and plantar warts.

Conditions

  • Common Wart
  • Plantar Wart

Interventions

DEVICE

Wortie freeze plus

treatment of common and plantar warts

Sponsors & Collaborators

  • Karo Pharma AB

    lead INDUSTRY

Principal Investigators

  • Agnieszka Cegielska, MD · Dermascan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-12
Primary Completion
2022-05-01
Completion
2022-05-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115669 on ClinicalTrials.gov